171 related articles for article (PubMed ID: 9529278)
21. Myocardial insulin resistance in patients with syndrome X.
Botker HE; Moller N; Schmitz O; Bagger JP; Nielsen TT
J Clin Invest; 1997 Oct; 100(8):1919-27. PubMed ID: 9329954
[TBL] [Abstract][Full Text] [Related]
22. Factors affecting myocardial 2-[F-18]fluoro-2-deoxy-D-glucose uptake in positron emission tomography studies of normal humans.
Choi Y; Brunken RC; Hawkins RA; Huang SC; Buxton DB; Hoh CK; Phelps ME; Schelbert HR
Eur J Nucl Med; 1993 Apr; 20(4):308-18. PubMed ID: 8491223
[TBL] [Abstract][Full Text] [Related]
23. Lumped constant for [(18)F]fluorodeoxyglucose in skeletal muscles of obese and nonobese humans.
Peltoniemi P; Lönnroth P; Laine H; Oikonen V; Tolvanen T; Grönroos T; Strindberg L; Knuuti J; Nuutila P
Am J Physiol Endocrinol Metab; 2000 Nov; 279(5):E1122-30. PubMed ID: 11052968
[TBL] [Abstract][Full Text] [Related]
24. Measurement of myocardial glucose uptake in patients with ischemic cardiomyopathy: application of a new quantitative method using regional tracer kinetic information.
Wiggers H; Bøttcher M; Nielsen TT; Gjedde A; Bøtker HE
J Nucl Med; 1999 Aug; 40(8):1292-300. PubMed ID: 10450680
[TBL] [Abstract][Full Text] [Related]
25. Metabolism substrate with negative myocardial uptake of iodine-123-BMIPP.
Kudoh T; Tamaki N; Magata Y; Konishi J; Nohara R; Iwasaki A; Ono S; Ohtake Y; Sugihara H; Sugihara H; Kuze K; Tsujimura Y; Miyazaki T
J Nucl Med; 1997 Apr; 38(4):548-53. PubMed ID: 9098200
[TBL] [Abstract][Full Text] [Related]
26. Feasibility, safety and image quality of cardiac FDG studies during hyperinsulinaemic-euglycaemic clamping.
Bax JJ; Visser FC; Poldermans D; van Lingen A; Elhendy A; Boersma E; Visser CA
Eur J Nucl Med Mol Imaging; 2002 Apr; 29(4):452-7. PubMed ID: 11914881
[TBL] [Abstract][Full Text] [Related]
27. Organ-specific insulin resistance in patients with noninsulin-dependent diabetes mellitus and hypertension.
Yokoyama I; Ohtake T; Momomura S; Yonekura K; Yamada N; Nishikawa J; Sasaki Y; Omata M
J Nucl Med; 1998 May; 39(5):884-9. PubMed ID: 9591594
[TBL] [Abstract][Full Text] [Related]
28. Significant suppression of myocardial (18)F-fluorodeoxyglucose uptake using 24-h carbohydrate restriction and a low-carbohydrate, high-fat diet.
Kobayashi Y; Kumita S; Fukushima Y; Ishihara K; Suda M; Sakurai M
J Cardiol; 2013 Nov; 62(5):314-9. PubMed ID: 23810066
[TBL] [Abstract][Full Text] [Related]
29. Mismatch between insulin-mediated glucose uptake and blood flow in the heart of patients with Type II diabetes.
Iozzo P; Chareonthaitawee P; Rimoldi O; Betteridge DJ; Camici PG; Ferrannini E
Diabetologia; 2002 Oct; 45(10):1404-9. PubMed ID: 12378381
[TBL] [Abstract][Full Text] [Related]
30. Simple method to quantify myocardial glucose metabolism from MB ratio in myocardial FDG PET.
Nishikawa J; Ohtake T; Yokoyama I; Watanabe T; Momose T; Sasaki Y
Ann Nucl Med; 1996 Aug; 10(3):323-8. PubMed ID: 8883708
[TBL] [Abstract][Full Text] [Related]
31. Myocardial 18F-FDG-PET. Experiences with the euglycemic hyperinsulinemic clamp technique.
Locher JT; Frey LD; Seybold K; Jenzer H
Angiology; 1995 Apr; 46(4):313-20. PubMed ID: 7726451
[TBL] [Abstract][Full Text] [Related]
32. Spatial heterogeneity in fasting and insulin-stimulated (18)F-2-deoxyglucose uptake in pigs with hibernating myocardium.
Fallavollita JA
Circulation; 2000 Aug; 102(8):908-14. PubMed ID: 10952961
[TBL] [Abstract][Full Text] [Related]
33. The effect of metabolic milieu on cardiac PET imaging using fluorine-18-deoxyglucose and nitrogen-13-ammonia in normal volunteers.
Berry JJ; Baker JA; Pieper KS; Hanson MW; Hoffman JM; Coleman RE
J Nucl Med; 1991 Aug; 32(8):1518-25. PubMed ID: 1869972
[TBL] [Abstract][Full Text] [Related]
34. Myocardial glucose metabolism in noninsulin-dependent diabetes mellitus patients evaluated by FDG-PET.
Ohtake T; Yokoyama I; Watanabe T; Momose T; Serezawa T; Nishikawa J; Sasaki Y
J Nucl Med; 1995 Mar; 36(3):456-63. PubMed ID: 7884509
[TBL] [Abstract][Full Text] [Related]
35. Variability of insulin-stimulated myocardial glucose uptake in healthy elderly subjects.
Kofoed KF; Hove JD; Freiberg J; Høst U; Holm S; Kelbaek H
Eur J Nucl Med Mol Imaging; 2002 Dec; 29(12):1600-7. PubMed ID: 12458394
[TBL] [Abstract][Full Text] [Related]
36. Effect of myocardial viability assessed by technetium-99m-sestamibi SPECT and fluorine-18-FDG PET on clinical outcome in coronary artery disease.
vom Dahl J; Altehoefer C; Sheehan FH; Buechin P; Schulz G; Schwarz ER; Koch KC; Uebis R; Messmer BJ; Buell U; Hanrath P
J Nucl Med; 1997 May; 38(5):742-8. PubMed ID: 9170439
[TBL] [Abstract][Full Text] [Related]
37. Effect of diabetes mellitus on myocardial 18F-FDG SPECT using acipimox for the assessment of myocardial viability.
Schinkel AF; Bax JJ; Valkema R; Elhendy A; van Domburg RT; Vourvouri EC; Bountioukos MA; Krenning EP; Roelandt JR; Poldermans D
J Nucl Med; 2003 Jun; 44(6):877-83. PubMed ID: 12791813
[TBL] [Abstract][Full Text] [Related]
38. Ketone Body Infusion With 3-Hydroxybutyrate Reduces Myocardial Glucose Uptake and Increases Blood Flow in Humans: A Positron Emission Tomography Study.
Gormsen LC; Svart M; Thomsen HH; Søndergaard E; Vendelbo MH; Christensen N; Tolbod LP; Harms HJ; Nielsen R; Wiggers H; Jessen N; Hansen J; Bøtker HE; Møller N
J Am Heart Assoc; 2017 Feb; 6(3):. PubMed ID: 28242634
[TBL] [Abstract][Full Text] [Related]
39. Nonuniformity in myocardial accumulation of fluorine-18-fluorodeoxyglucose in normal fasted humans.
Gropler RJ; Siegel BA; Lee KJ; Moerlein SM; Perry DJ; Bergmann SR; Geltman EM
J Nucl Med; 1990 Nov; 31(11):1749-56. PubMed ID: 2230987
[TBL] [Abstract][Full Text] [Related]
40. Increased uptake of iodine-123-BMIPP in chronic ischemic heart disease: comparison with fluorine-18-FDG SPECT.
Sloof GW; Visser FC; Bax JJ; van Lingen A; Eersels J; Knapp FF; Teule GJ
J Nucl Med; 1998 Feb; 39(2):255-60. PubMed ID: 9476931
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
